✦ LIBER ✦

Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B

✍ Scribed by Kindler, Hedy L.; Millard, Frederick; Herndon II, James E.; Vogelzang, Nicholas J.; Suzuki, Yasunosuke; Green, Mark R.

Book ID: 118569460
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 86 KB
Volume: 31
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)00166-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine in malignant mesothelioma:

Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)

✍ Otterson, Gregory A; Herndon, James E; Watson, Dorothy; Green, Mark R; Kindler, 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Vatalanib in malignant mesothelioma: A p

Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)

✍ Jahan, Thierry; Gu, Lin; Kratzke, Robert; Dudek, Arkadiusz; Otterson, Gregory A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Randomized phase II trial of cisplatin w

Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Carboplatin in malignant mesothelioma: A

Carboplatin in malignant mesothelioma: A phase II study of the cancer and leukemia Group B

✍ Nicholas J. Vogelzang; Maria Goutsou; Joseph M. Corson; Yasunosuke Suzuki; Steph 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 408 KB

Dihydro-5-azacytidine and cisplatin in t

Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma : A phase II study by the Cancer and Leukemia Group B

✍ Brian L. Samuels; James Herndon II; David C. Harmon; Robert Carey; Joseph Aisner 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

## BACKGROUND. In a prior Cancer and Leukemia Group B (CALGB) Phase II trial of

Edatrexate (10-ethyl-deaza-aminopterin)

Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma : Sequential Phase II trials by the Cancer and Leukemia Group B

✍ Hedy L. Kindler; Chandra P. Belani; James E. Herndon II; Nicholas J. Vogelzang; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

The Cancer and Leukemia Group B (CALGB) conducted sequential Phase II multicenter trials to evaluate the activity of edatrexate alone (E) or with leucovorin rescue (EL) in patients with malignant pleural mesothelioma (CALGB Protocol 9131).